Delivery of manganese carbonyl to the tumor microenvironment using Tumor-Derived exosomes for cancer gas therapy and low dose radiotherapy.

The development of novel radiosensitizer with high selectivity and controllability is highly desirable. CO gas could cause damage to mitochondria and thus enhance RT effect. Controlled delivery of CO in tumor is important both to achieve high-efficiency of CO gas therapy and to decrease the risk of CO poisoning. In this study, manganese carbonyl (MnCO) loaded exosome nano-vesicles (MMV) to overcome this conundrum for tumor therapy is developed. After administration, MMV showed its admirable performance in active tumor-targeting, mitochondria damage and radiosensitization therapy. These MMV nanoparticles were able to facilitate robust CO evolution and consequent ROS generation in response to X-ray irradiation both in vitro and in vivo. Significantly, MMV could facilitate a 90% inhibition effect of tumor growth under very low dose (only 2Gy) RT, which is better than high dose (6Gy) radiotherapy. Overall, this study highlights a novel and practical approach to enhancing the efficacy of tumor RT, underscoring the value of future research in the field of CO medicine.

High-efficient energy recovery from organics degradation for neutral wastewater treatment based on radicals catalytic reaction of Fe2+/Fe3+-EDTA complexes.

A high-efficient photo-induced wastewater fuel cell (WFC) for neutral wastewater treatment was proposed in this paper based on radicals catalytic reaction of Fe3+/Fe2+- EDTA complexes in the system which has a lower redox potential than Fe3+/Fe2+ and can accelerate easily the conversion of slow catalytic step from Fe (III) to Fe (II). The results indicated that the WFC shows an excellent performance in a wide pH range of 5-9 and achieves optimal efficiency for organic degradation and electricity generation at pH 7.0. The removal ratio of organic pollutants (Rhodamine b, Phenol, and Methylene Blue) increased to 69.42%, 53.99% and 82.7% from 29.87%, 16.25% and 39% respectively after 3 h operation at an initial pH of 7.0. Meanwhile, the short-circuit current is up to 1.24-2.16 times that of the WFC without EDTA-ferrous complex. Furthermore, the system almost does not produce any sludge. The proposed WFC system can keep stable of Fe3+/Fe2+ in neutral solution and generate more intermediate active free radicals to treat neutral wastewater and recover the abundant chemical energy in organics.

Phased surgical treatment of barium enema-induced rectal injury and retention of barium in the pelvic floor space.

Iatrogenic injuries caused by barium enema are rarely reported. Following a phased surgical protocol for up to one year, we have successfully treated a patient with rectal injury and severe infection of the pelvic floor space complicated with retention of large amounts of barium and vaginal fistula. In this article, the phased surgery planning for the treatment of rectal injury complicated with vaginal fistula is discussed in terms of the pros and cons, and the observed effect and evolution of barium retained in the pelvic floor space are described.

[Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer].

OBJECTIVE: To explore the effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) on the postoperative metastatic rate and survival rate of advanced gastric cancer (AGC). METHODS: In HIIC group, patients received HIIC (mitomycin C 30 mg and cisplatin 100 mg were added into 2000 ml distilled water, heated to 42 approximately 45 degrees C, perfused to abdominal cavity for 30 min and then sucked) and intravenous chemotherapy after operation (5- FU 10 approximately 15 mg/kg, mitomycin C 0.1 approximately 0.15 mg/kg, adriamycin 0.5 approximately 1 mg/kg i.v drip, once a week for 2 approximately 3 weeks). In control group, patients received intravenous chemotherapy only. The postoperative metastatic rate and survival rate (1- , 3- and 5- year) of patients were compared between 92 cases of AGC undergone HIIC and 120 cases of AGC without HIIC (control group). RESULTS: The peritoneal recurrence rates after operations occurred within two years were 14.1% and 37.5% in HIIC group and control group respectively (P < 0.01). The 1- , 3- , and 5- year survival rates in HIIC group were 98.9%, 68.5%, and 52.2% and in control group 95.0%, 56.7% and 37.5% respectively. The 3- , and 5- year survival rates were significantly different between the two the groups (P < 0.05). CONCLUSION: HIIC can kill isolated intraperitoneal cancer cells, reduce peritoneal recurrence rate after operations, raise significantly survival rate of patient, and improve the prognosis of AGC.